Mandate

Vinge has advised Ingrid Capacity in new co-operation with Locus Energy, one of SEB Nordic Energy's portfolio companies

March 07, 2025 M&A

Vinge has advised Ingrid Capacity in connection with a new project together with Locus Energy, a leading Nordic energy infrastructure company owned by SEB Asset Management's SEB Nordic Energy fund, to develop Finland's largest and one of the Nordic region's largest battery storage systems.

The parties entered into a strategic partnership last year to increase the capacity of the national electricity grid and have now made a new joint investment in Finland's largest battery energy storage system, located in Nivala, Finland. The Nivala project is the second project of the partnership and a part of Ingrid Capacity's long-term vision to enable a resilient, cost-effective and sustainable electricity grid. The facility, which is planned to be commissioned in 2026, has a capacity of 70MW/140MWh and will be managed by Ingrid Capacity's proprietary and fully automated trading and optimisation platform, an advanced AI-powered software designed to make real-time decisions.

Vinge's team consisted primarily of Carl Sander, Vilhelm Rondahl, and Ellenor Eckerborn (M&A).

Please find more information here.

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025